|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net loss to cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Impairments | |||||
| Amortization of deferred financing costs | |||||
| Loss from discontinued operations, net of tax | |||||
| Provision for doubtful accounts | |||||
| Gain on sale of property, plant and equipment | |||||
| Equity in income of non-consolidated affiliates | |||||
| Gain (loss) on remeasurement of intercompany balances | |||||
| Loss on foreign currency derivatives | |||||
| Loss on sale of businesses | |||||
| Gain on extinguishment of debt | |||||
| Stock-based compensation expense | |||||
| Deferred income tax provision | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable and notes | |||||
| Inventory | |||||
| Costs and estimated earnings versus billings on uncompleted contracts | |||||
| Contract assets | |||||
| Contract assets and contract liabilities, net | |||||
| Other current assets | |||||
| Accounts payable and other liabilities | |||||
| Deferred revenue | |||||
| Contract liabilities | |||||
| Other | |||||
| Net cash provided by continuing operations | |||||
| Net cash used in discontinued operations | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from sale of businesses | |||||
| Settlement of foreign currency derivatives | |||||
| Net cash used in continuing operations | |||||
| Net cash provided by discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from borrowings of debt | |||||
| Repayments of debt | |||||
| Cash transfer from Archrock, Inc. | |||||
| Payments for debt issuance costs | |||||
| Proceeds from stock options exercised | |||||
| Purchases of treasury stock | |||||
| Net cash provided by financing activities | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Income taxes paid, net | |||||
| Interest paid, net of capitalized amounts | |||||
| Supplemental disclosure of non-cash transactions: | |||||
| Accrued capital expenditures | |||||
| Non-cash proceeds from sale of business | |||||
Loading...